Tag Archives: pneumonia

Angola rolls out pneumococcal vaccination program for children

GAVI

TweetAngola celebrated June 3 as it officially began its pneumococcal vaccination program for children under five years old, as part of the GAVI Alliance’s vision to see developing nations gain access to the vaccine. Angola is the 28th country to … Read More »

Filed in Vaccine Development | Tagged , | 1 Comment

GAVI funds new pneumonia immunization program in Uganda

GAVI

TweetA new immunization initiative, funded by the GAVI Alliance, will reach 1.4 million children in Uganda and protect them against pneumonia and other diseases as part of progress towards the 2015 Millennium Development Goals. The pneumococcal conjugate vaccine that will … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

New U.N. plan seeks higher targets for pneumonia and diarrhea treatment

Pneumonia

Tweet The United Nations launched a global plan on Friday to save two million children under the age of five annually who would otherwise die from diarrhea and pneumonia in low income countries. The U.N.’s World Health Organization launched the … Read More »

Filed in Medical Countermeasures, World Health Organization | Tagged , , | Comments Off

Three die from MRSA and influenza infections in Maryland

TweetAccording to the Maryland Department of Health and Mental Hygiene, five members of a Lusby, Maryland, family came down with methicillin-resistant Staphylococcus aureus pneumonia along with influenza and three died from the infection. Ruth Blake and her adult children, Lowell … Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

FDA approves Prevnar for adults over 50

On December 30, the U.S. Food and Drug Administration announced the approval of Prevnar 13, Pfizer’s pneumococcal vaccine, for use in adults aged 50 and older. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Pfizer, GSK to discount pneumonia vaccines by more than 50 percent

The sales of low-priced pneumonia vaccine to developing countries by Pfizer and GlaxoSmithKline will increase by more than 50 percent in the coming months. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Discovery could improve efficacy of pneumonia vaccines

Scientists recently discovered how a novel type of antibody fights pneumococcal bacteria, a finding that could improve the efficacy of vaccines against pneumonia. Read More »

Filed in News, Vaccine Development | Tagged | Comments Off

Pneumonia vaccine found safe for those over 50

In two clinical trials by pharmaceutical company Pfizer, Prevnar 13, its pneumonia vaccine, was found to be effective for patients ages 50 and up. Read More »

Filed in News, Vaccine Development | Tagged | Comments Off

Vaccine breakthrough may protect against deadly form of pneumonia

Drop in pneumonia cases linked to increase in vaccinations

Vaccine may prevent infant pneumonia infection

India’s health ministry to initiate impact study on pneumococcal conjugate vaccine

Pfizer wins Europe approval for new vaccine

FDA wants panel to probe Pfizer vaccine efficacy

Scientists create NICE solution to pneumonia vaccine testing problems

Global health organizations urge governments to fight pneumonia